Evvy secures $40m to validate AI-based women’s health diagnostics

Evvy has raised $40m in an oversubscribed Series B round to advance and validate its AI-powered diagnostic and care models for women’s health. The funds will support validation of EvvyAI-powered diagnostic models and expand distribution through medical professionals. Evvy has developed a clinical-grade dataset focused on the vaginal microbiome and related women’s health outcomes. Credit: Orawan Pattarawimonchai / Shutterstock.com. Evvy has raised $40m in an oversubscribed Series B funding round to advance and validate its AI-powered diagnostic and care models for women’s health. The round was led by Catalio Capital Management, with participation from Rethink Impact, Muse Capital, and Alumni…

Source: Medical Device Network